Crossmark

Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies

Crossref DOI link: https://doi.org/10.1186/s13613-024-01372-5

Published Print: 2024

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Bredin, Swann

Decroocq, Justine

Devautour, Clément

Charpentier, Julien

Vigneron, Clara

Pène, Frédéric https://orcid.org/0000-0003-3639-3849
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-024-01372-5

Content Type: article

Copyright: Copyright © 2024 The Author(s) 2024. Published by Elsevier Masson SAS